Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) is a hard stock to understand if you think of it as a company. But if you shift ...
Maserati introduces a new 483-hp GranCabrio, offering open-top thrills with a twin-turbo V6 and a lower entry price than the ...
USFDA issued a Form 483 with three observations to Gland Pharma's facility in Visakhapatnam after a pre-approval inspection for sterile APIs. The observations are procedural in nature and will be ...
In a regulatory filing, Gland Pharma said, "...the United States Food and Drug Administration (USFDA) has conducted a ...
Syngene International declined 1.34% to Rs 704.35 after the United States Food and Drug Administration (USFDA) issued Form 483 with five observations to the company's Bengaluru facility.
Maserati unveils the new 483-HP GranCabrio and bespoke Trofeo ONE of ONE at The I.C.E. St Moritz, showcasing luxury and ...
House Bill 483 aims to provide $56 million in property tax relief and maintain stable school funding
MONTANA - Lawmakers in Montana are considering House Bill 483, known as "The Right Back Act," which proposes to return $56 ...
Berkshire Hathaway's B shares hit an all-time high of $483 per share in late 2024. The stock is just a few percentage points below that high. Here's why buying Berkshire Hathaway while it is still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback